Atlas Trials

Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease

Clinical trial NCT00962988 · COMPLETED

Trial details

NCT number
NCT00962988
Sponsor
Ottawa Heart Institute Research Corporation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cerebrovascular DisordersSmoking Cessation
Start date
2009-12-01
Primary completion
2015-04-01
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.